Mitchell Machtay - Concepedia

Author

Mitchell Machtay

Also Known As

M MACHTAY, M Machtay, M. Machtay, M.X. Machtay, MITCHELL MACHTAY, Michell Machtay, Mitchell Machtay, Mitchell X. Machtay, Virginia Livolsi, Wendy Seiferheld

498

Publications

20.3K

Citations

H-Index

137

Concepts

All Affiliations

Case Western Reserve University University of Pennsylvania The University of Texas MD Anderson Cancer Center RTOG Foundation Thomas Jefferson University

About

Mitchell Machtay is an author at Case Western Reserve University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	85	6.1K
2	Health Sciences	25	44	2.7K
3	Engineering	5	5	368
4	Public Health	2	2	38
5	Natural Sciences	1	1	14

Mitchell Machtay

164

Publications

18.5K

Citations

H-Index

Page 1

	Year	Citations
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, New England Journal of Medicine	2004	3.2K
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis Mitchell Machtay, Jennifer Moughan, A. Trotti, Journal of Clinical Oncology	2008	1.3K
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 Walter J. Curran, Rebecca Paulus, Corey J. Langer, JNCI Journal of the National Cancer Institute	2011	1.2K
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Miljenko V. Pilepich, Kathryn Winter, Madhu J. John, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation MedicineRadiation TherapyMedicineAndrogen Deprivation Adjuvant	2001	774
Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413 Mack Roach, Michelle DeSilvio, C.A. Lawton, Journal of Clinical Oncology	2003	638
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate C.A. Lawton, Kathryn Winter, Kevin Murray, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation TherapyMedicineStandard Radiation TherapyProstatic Disease	2001	377
Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck Sharon A. Spencer, Jonathan Harris, Richard Wheeler, Head & Neck	2007	358
Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Anjali Gupta, W. Gillies McKenna, Charles N. Weber, PubMed	2002	348
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group Mitchell Machtay, Kyounghwa Bae, Benjamin Movsas, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyMedicineImproved OutcomesOncology	2010	299
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer Theodore J. Robnett, Mitchell Machtay, Eugene F Vines, International Journal of Radiation OncologyBiologyPhysics Severe Radiation PneumonitisDefinitive ChemoradiationRadiation TherapyAdvanced Lung DiseaseMedicine	2000	298

Page 1